Gold and Silver Nanoparticles Synthesis and Applications
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an early-stage preclinical study demonstrating proof-of-concept for a novel theranostic nanoparticle in mouse models of TNBC, with no human data, no clinical outcomes, and no comparison to standard surgical or immunotherapeutic approaches.
Early-stage proof-of-concept study demonstrating a novel nanomaterial's feasibility for tumor imaging in vivo, without comparison to a standard imaging agent or clinical validation.
A narrative review summarizing preclinical and theoretical potential of gold nanoparticles in prostate cancer, without presenting original experimental data, clinical trials, or quantified outcomes.
This is a mechanistic, in vitro comparative study of nanoparticle toxicity across cell types and conditions, offering structure–activity insights but lacking efficacy data, clinical endpoints, or in vivo validation necessary to guide therapeutic development.